{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:05:09Z","timestamp":1779926709995,"version":"3.53.1"},"reference-count":54,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2023.12171","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T07:00:30Z","timestamp":1692255630000},"source":"Crossref","is-referenced-by-count":2,"title":["27\u2011Gauge vitrectomy vs. 25\u2011gauge vitrectomy in the management of proliferative diabetic retinopathy with preoperative intravitreal injection of conbercept"],"prefix":"10.3892","volume":"26","author":[{"given":"Wu","family":"Xiang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat\u2011sen University, Guangzhou, Guangdong 510060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Fang","sequence":"additional","affiliation":[{"name":"Shenzhen Eye Hospital Affiliated to Jinan University, Shenzhen, Guangdong 518040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat\u2011sen University, Guangzhou, Guangdong 510060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaotian","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat\u2011sen University, Guangzhou, Guangdong 510060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqi","family":"Xiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat\u2011sen University, Guangzhou, Guangdong 510060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofen","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat\u2011sen University, Guangzhou, Guangdong 510060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaochong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shenzhen Eye Hospital Affiliated to Jinan University, Shenzhen, Guangdong 518040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Wei","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat\u2011sen University, Guangzhou, Guangdong 510060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"issue":"e45264","key":"key20231010100536_b1-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045264","article-title":"Prevalence of diabetic retinopathy in mainland China: A meta-analysis","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"key20231010100536_b2-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.4103\/ijo.IJO_1293_21","article-title":"Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus-A comparative observational study","volume":"69","author":"Kumar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"key20231010100536_b3-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.4103\/ijo.IJO_1217_18","article-title":"Current management of diabetic tractional retinal detachments","volume":"66","author":"Stewart","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"key20231010100536_b4-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.ophtha.2003.08.043","article-title":"Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: Ultrasound biomicroscopy findings","volume":"111","author":"Hershberger","year":"2004","journal-title":"Ophthalmology"},{"key":"key20231010100536_b5-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.ophtha.2011.03.036","article-title":"The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy","volume":"118","author":"Ahn","year":"2011","journal-title":"Ophthalmology"},{"key":"key20231010100536_b6-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/s0161-6420(02)01119-3","article-title":"Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery","volume":"109","author":"Fujii","year":"2002","journal-title":"Ophthalmology"},{"key":"key20231010100536_b7-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ophtha.2009.06.043","article-title":"A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery","volume":"117","author":"Oshima","year":"2010","journal-title":"Ophthalmology"},{"key":"key20231010100536_b8-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"86","DOI":"10.12669\/pjms.331.11617","article-title":"Outcomes of transconjunctival sutureless 27-gauge micro-incision vitrectomy surgery in diabetic vitreous haemorrhage","volume":"33","author":"Shahzadi","year":"2017","journal-title":"Pak J Med Sci"},{"key":"key20231010100536_b9-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ajo.2015.09.024","article-title":"Outcomes of 27 gauge microincision vitrectomy surgery for posterior segment disease","volume":"161","author":"Khan","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"6428","key":"key20231010100536_b10-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216428","article-title":"Advances in vitreoretinal surgery","volume":"11","author":"Ribeiro","year":"2022","journal-title":"J Clin Med"},{"key":"key20231010100536_b11-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/IAE.0000000000000411","article-title":"Comparison of attraction capabilities associated with high-speed, dual-pneumatic vitrectomy probes","volume":"35","author":"Dugel","year":"2015","journal-title":"Retina"},{"key":"key20231010100536_b12-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/IAE.0b013e3182456f4d","article-title":"Tissue attraction associated with 20-gauge, 23-gauge, and enhanced 25-gauge dual-pneumatic vitrectomy probes","volume":"32","author":"Dugel","year":"2012","journal-title":"Retina"},{"issue":"582060","key":"key20231010100536_b13-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/582060","article-title":"Diabetic retinopathy: Vascular and inflammatory disease","volume":"2015","author":"Semeraro","year":"2015","journal-title":"J Diabetes Res"},{"key":"key20231010100536_b14-ETM-26-4-12171","first-page":"2408","article-title":"VEGF-initiated blood-retinal barrier breakdown in early diabetes","volume":"42","author":"Qaum","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20231010100536_b15-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/S0161-6420(03)00568-2","article-title":"Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema","volume":"110","author":"Funatsu","year":"2003","journal-title":"Ophthalmology"},{"key":"key20231010100536_b16-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ajo.2010.03.016","article-title":"Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection","volume":"150","author":"Kohno","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"18880","key":"key20231010100536_b17-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75896-8","article-title":"Perioperative anti-vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: A network meta-analysis","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"key20231010100536_b18-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1097\/IAE.0000000000000723","article-title":"Anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy: A systematic review and meta-analysis","volume":"35","author":"Simunovic","year":"2015","journal-title":"Retina"},{"key":"key20231010100536_b19-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ophtha.2010.08.008","article-title":"A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration","volume":"118","author":"Zhang","year":"2011","journal-title":"Ophthalmology"},{"issue":"2473234","key":"key20231010100536_b20-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2473234","article-title":"A randomized controlled trial of conbercept pretreatment before vitrectomy in proliferative diabetic retinopathy","volume":"2016","author":"Yang","year":"2016","journal-title":"J Ophthalmol"},{"key":"key20231010100536_b21-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.18240\/ijo.2018.07.23","article-title":"Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy","volume":"11","author":"Mao","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"key20231010100536_b22-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"139","DOI":"10.18240\/ijo.2023.01.21","article-title":"Silicone oil injection and removal in 27-gauge vitreous surgery","volume":"16","author":"Kitagawa","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"key20231010100536_b23-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/eye.2009.206","article-title":"Comparison of 25- and 23-gauge sutureless microincision vitrectomy surgery in the treatment of various vitreoretinal diseases","volume":"24","author":"Nam","year":"2010","journal-title":"Eye (Lond)"},{"key":"key20231010100536_b24-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000360449","article-title":"27-Gauge vitrectomy","volume":"54","author":"Osawa","year":"2014","journal-title":"Dev Ophthalmol"},{"key":"key20231010100536_b25-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4103\/0974-9233.120003","article-title":"Surgical management of diabetic retinopathy","volume":"20","author":"Gupta","year":"2013","journal-title":"Middle East Afr J Ophthalmol"},{"key":"key20231010100536_b26-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/eye.2015.275","article-title":"Comparative study of 27-gauge vs 25-gauge vitrectomy for epiretinal membrane","volume":"30","author":"Mitsui","year":"2016","journal-title":"Eye (Lond)"},{"key":"key20231010100536_b27-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/IAE.0000000000002839","article-title":"Retinal sensitivity and vessel density after macular hole surgery with the superior inverted internal limiting membrane flap technique","volume":"41","author":"Kunikata","year":"2021","journal-title":"Retina"},{"issue":"e0249139","key":"key20231010100536_b28-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249139","article-title":"Comparison of 27-gauge and 25-gauge vitrectomy in the management of tractional retinal detachment secondary to proliferative diabetic retinopathy","volume":"16","author":"Chen","year":"2021","journal-title":"PLoS One"},{"key":"key20231010100536_b29-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s10792-018-1030-z","article-title":"Surgical outcomes of 27-gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy","volume":"39","author":"Naruse","year":"2019","journal-title":"Int Ophthalmol"},{"key":"key20231010100536_b30-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1097\/IAE.0000000000000545","article-title":"Twenty-seven-gauge vitrectomy for various vitreoretinal diseases","volume":"35","author":"Rizzo","year":"2015","journal-title":"Retina"},{"key":"key20231010100536_b31-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/IAE.0000000000001215","article-title":"Twenty-seven-gauge versus 25-gauge vitrectomy for primary rhegmatogenous retinal detachment","volume":"37","author":"Romano","year":"2017","journal-title":"Retina"},{"issue":"6384985","key":"key20231010100536_b32-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6384985","article-title":"Comparative study of 27-gauge versus 25-gauge vitrectomy for the treatment of primary rhegmatogenous retinal detachment","volume":"2017","author":"Rizzo","year":"2017","journal-title":"J Ophthalmol"},{"key":"key20231010100536_b33-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3928\/23258160-20170601-02","article-title":"Making the jump to 27-gauge vitrectomy: Perspectives","volume":"48","author":"Kasi","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key20231010100536_b34-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/OPTH.S16414","article-title":"Comparison of retinal breaks observed during 23 gauge transconjunctival vitrectomy versus conventional 20 gauge surgery for proliferative diabetic retinopathy","volume":"5","author":"Issa","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"key20231010100536_b35-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ajo.2013.02.008","article-title":"Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: A meta-analysis of randomized controlled trials","volume":"156","author":"Zhang","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"key20231010100536_b36-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.4.1.6","article-title":"Performance comparison of high-speed dual-pneumatic vitrectomy cutters during simulated vitrectomy with balanced salt solution","volume":"4","author":"Abulon","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"key20231010100536_b37-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/OPTH.S71387","article-title":"Vitreous flow rates through dual pneumatic cutters: Effects of duty cycle and cut rate","volume":"9","author":"Abulon","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"key20231010100536_b38-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1159\/000328207","article-title":"Vitrectomy fluidics","volume":"226 (Suppl 1)","author":"Steel","year":"2011","journal-title":"Ophthalmologica"},{"key":"key20231010100536_b39-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/APO.0000000000000192","article-title":"Endophthalmitis after pars plana vitrectomy: Clinical features, risk factors, and management outcomes","volume":"5","author":"Dave","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"key20231010100536_b40-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ajo.2004.12.002","article-title":"Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy","volume":"139","author":"Ibarra","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key20231010100536_b41-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/IAE.0b013e31816c6855","article-title":"Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes","volume":"28","author":"Hsu","year":"2008","journal-title":"Retina"},{"key":"key20231010100536_b42-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1136\/bjo.2010.189514","article-title":"A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy","volume":"95","author":"Zhao","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"1067670","key":"key20231010100536_b43-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1067670","article-title":"Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial","volume":"10","author":"Qu","year":"2023","journal-title":"Front Public Health"},{"issue":"1098","key":"key20231010100536_b44-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.3390\/life13051098","article-title":"Update on the management of diabetic retinopathy: Anti-VEGF agents for the prevention of complications and progression of nonproliferative and proliferative retinopathy","volume":"13","author":"Bahr","year":"2023","journal-title":"Life (Basel)"},{"key":"key20231010100536_b45-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2147\/JEP.S259298","article-title":"Current and future anti-VEGF agents for neovascular age-related macular degeneration","volume":"13","author":"Kaiser","year":"2021","journal-title":"J Exp Pharmacol"},{"key":"key20231010100536_b46-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ophtha.2022.06.042","article-title":"A network meta-analysis of retreatment rates following bevacizumab, ranibizumab, aflibercept, and laser for retinopathy of prematurity","volume":"129","author":"Chang","year":"2022","journal-title":"Ophthalmology"},{"key":"key20231010100536_b47-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","article-title":"Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study","volume":"121","author":"Li","year":"2014","journal-title":"Ophthalmology"},{"issue":"e70544","key":"key20231010100536_b48-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070544","article-title":"Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"key20231010100536_b49-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1053\/sonc.2002.37264","article-title":"Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications","volume":"29 (6 Suppl 16)","author":"Ferrara","year":"2002","journal-title":"Semin Oncol"},{"key":"key20231010100536_b50-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/IAE.0000000000000900","article-title":"INTRAVITREAL conbercept (KH902) for surgical treatment of severe proliferative diabetic retinopathy","volume":"36","author":"Su","year":"2016","journal-title":"Retina"},{"key":"key20231010100536_b51-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1097\/IAE.0b013e31820a68e5","article-title":"Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage","volume":"31","author":"Farahvash","year":"2011","journal-title":"Retina"},{"key":"key20231010100536_b52-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1177\/112067210901900526","article-title":"Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy","volume":"19","author":"Modarres","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"key20231010100536_b53-ETM-26-4-12171","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s40123-023-00664-6","article-title":"Effect of adjunctive intravitreal conbercept injection at the end of 25G vitrectomy on severe proliferative diabetic retinopathy: 6-month outcomes of a randomised controlled trial","volume":"12","author":"Li","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"5304524","key":"key20231010100536_b54-ETM-26-4-12171","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5304524","article-title":"Outcomes of 25-gauge vitrectomy for tractional and nontractional diabetic macular edema with proliferative diabetic retinopathy","volume":"2019","author":"Someya","year":"2019","journal-title":"J Ophthalmol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T07:10:04Z","timestamp":1696921804000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2023.12171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,17]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2023.12171","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"article-number":"472"}}